Longview Acquisition Corp. II
LGV-UN
New York Stock Exchange10.08
USD
- -
- -
CIK
0001832300
Return %
Stock
S&P500
1Y
3.07
26.84
3Y
-0.49
77.03
5Y
-0.49
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- John David Rodin
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 767 Fifth Avenue New York City NY United States of America 10153
- CIK
- 0001832300
- Website
- longviewacquisition.com
- Similar Companies
- Business
- Longview Acquisition Corp. II (NYSE: LGV-UN) operates as a blank check company whose sole purpose is to pursue a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, with a particular focus on the healthcare, industrials, consumer, media, technology, and technology services sectors; it generates no significant independent operations or revenue prior to completing such a transaction. Incorporated in 2020 and headquartered in New York, New York, the company raised $600 million in its initial public offering in March 2021 through 60 million units at $10.00 each, underwritten by UBS Securities LLC and Cowen and Company, LLC, with units separating into Class A common stock and redeemable warrants thereafter. Longview Acquisition Corp. II targets industries aligned with its sponsor's expertise from Glenview Capital Management, LLC, primarily healthcare innovators and technology-enabled firms serving enterprise, government, and consumer markets across the United States and select international regions. In July 2021, the company announced a definitive business combination agreement with HeartFlow, Inc., valuing the combined entity at a $2.4 billion enterprise value, but the parties mutually terminated the deal in February 2022 due to unfavorable market conditions. Subsequently, in December 2022, shareholders approved amendments to the charter and trust agreement extending the business combination deadline to December 14, 2022, after which most public shares were redeemed at approximately $10.06 per share; the company liquidated, NYSE suspended trading and delisted its securities, and it filed to terminate SEC registration, though certain financial metrics and units persist in limited trading contexts as of late 2025. No further mergers, acquisitions, funding rounds, product launches, or operational expansions have materialized since liquidation, rendering the entity inactive for new business combinations.
Larry Robbins' Firm Jumps Into Longview Acquisition Corp